Phase 3 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The inclusion criteria section does not list any specific requirements for joining this part of the trial (confirm with trial site)
Who may not be able to join:
- People who have previously had, or are planned to have, a stem cell transplant using cells from another person
- People who are already taking antibiotic tablets, capsules, or infusions specifically to prevent bacterial infections (note: preventive treatments for viral, fungal, or a specific lung infection called PJP are not a barrier)
- People who have received an immunoglobulin infusion or injection in the past three months
- People who have objections to receiving immunoglobulin products (a type of treatment made from donated blood)
- People who have a known condition called IgA deficiency combined with anti-IgA antibodies
- People with a history of a severe allergic reaction to immunoglobulin products
- People who currently have an active infection that is being treated with antibiotics
- People who are allergic or intolerant to all of the antibiotic options available in this part of the trial
- People who are pregnant or breastfeeding
- People with severely reduced kidney function (confirm with trial site for the specific measurement used)
- People who have previously had their spleen removed
- People who have already taken part in this section of the trial before
- People whose treating doctor considers that joining this part of the trial would not be in their best interest
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zoe McQuilten, Professor, Monash University
Australian sites
+61 (8) 7074 5898
+61 (03) 9070 5741
+61 (03) 8408 6000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
3 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Event-free survival (EFS).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.